JIN WANG to Multiple Myeloma
This is a "connection" page, showing publications JIN WANG has written about Multiple Myeloma.
Connection Strength
0.087
-
Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun. 2021 02 15; 12(1):1022.
Score: 0.087